Over the last 10 years, West Pharmaceutical Services stock has attracted buying interest at this level 7 times and has subsequently produced an average ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

Phio Pharmaceuticals Corp. PHIO shares are up on Tuesday’ as the company announced positive results from its Phase 1b clinical trial for its lead candidate, PH-762. The $9 million market cap biotech ...

The clinical-stage siRNA biopharmaceutical company announced that its INTASYL compound PH-762 achieved an 85% pathological response rate in the final cohort, with 6 of 7 patients responding to ...

Corvus Pharma (NASDAQ: CRVS) has outperformed the market over the past 5 years by 29.68% on an annualized basis producing an average annual return of 42.78%. Currently, Corvus Pharma has a market ...

The International Directory of Pharmaceutical Companies offers opportunities to profile markets, build prospects, connect with key executives, and identify competitors. It aids in discovering ...

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2026 / New to The Street, the nationally syndicated, long-form ...